Treceți offline cu aplicația Player FM !
Roche wins FDA approval for subcutaneous cancer immunotherapy, Moderna to cut $1.1B in R&D expenses, Teva settles $80M opioid case with Baltimore [The good, the bad, the ugly]
Manage episode 440320088 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Roche snags FDA nod for subcutaneous cancer immunotherapy
The bad — Moderna to cut R&D expenses by $1.1B
The ugly — Teva reaches $80M opioid settlement with Baltimore
77 episoade
Manage episode 440320088 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Roche snags FDA nod for subcutaneous cancer immunotherapy
The bad — Moderna to cut R&D expenses by $1.1B
The ugly — Teva reaches $80M opioid settlement with Baltimore
77 episoade
Toate episoadele
×Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.